Relmada Therapeutics, Inc. (RLMD)

7.26 +0.02 (+0.28%) USD  |  NASDAQ  |  Apr 29, 15:00
More

Relmada Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Avalo Therapeutics, Inc. Upgrade
AN2 Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade